JMS Co

JMS Co Pre-Tax Margin

The Pre-Tax Profit Margin of JMS Co (7702.T) as of Nov 2, 2026 is -0.56 %. In the previous year, Pre-Tax Profit Margin was 0.80 % — a change of -169.49% (lower).

Pre-Tax Margin

-0.56 %

YoY

-169.49%

Last updated:

Pre-Tax Profit Margin of JMS Co is 2026 -0.56 % . Pre-Tax Profit Margin of JMS Co was 2025 0.80 % . It decreases by -169.49% lower compared to the previous year.

The JMS Co Pre-Tax Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Pre-Tax Margin
Date
Pre-Tax Margin
Jan 1, 2019
2.55 JPY
Jan 1, 2020
4.38 JPY
Jan 1, 2021
3.86 JPY
Jan 1, 2022
1.85 JPY
Jan 1, 2023
0.97 JPY
Jan 1, 2024
0.22 JPY
Jan 1, 2025
0.80 JPY
Jan 1, 2026
-0.56 JPY
The JMS Co Pre-Tax Margin history
YEARPre-Tax MarginYoY
-0.56 %-169.49%
0.80 %+262.17%
0.22 %-77.17%
0.97 %-47.37%
1.85 %-52.11%
3.86 %-11.95%
4.38 %+71.94%
2.55 %+94.70%
1.31 %-33.85%
1.98 %-5.33%
2.09 %+186.70%
0.73 %-59.96%
1.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

Pre-Tax Profit Margin of JMS Co is -0.56 % in 2026.

Pre-Tax Profit Margin of JMS Co changed from 0.80 % to -0.56 %, representing a -169.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Pre-Tax Profit Margin JMS Co since 2006 – with annual values, charts, and detailed analysis.

Pre-tax margin measures the percentage of revenue remaining after all expenses except income taxes. It isolates operational and financial performance from tax effects.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Pre-Tax Profit Margin's JMS Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Pre-Tax Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Pre-Tax Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — JMS Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — JMS Co